# A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS

> **NCT00722800** · PHASE2 · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 4 (actual)

## Conditions studied

- Hidradenitis Suppurativa

## Interventions

- **DRUG:** drospirenone and ethinyl estradiol (YAZ)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00722800
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-10
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Poor recruitment
- **Last updated:** 2014-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00722800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00722800, "A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00722800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*